However, HOXC-AS2 was elevated and HOXC-AS2 knockdown suppressed the invasion, migration, and EMT process in glioma and non-small cell lung cancer.25,26 Furthermore, high HOXC-AS2 expression in STAD had a high survival rate while a poor survival rate in PAAD, indicating that HOXC-AS2 may exert different effects in various cancer types. The gene discussed is HOXC-AS2; the disease is glioma.